Dibitetto Diego, Sims Jennie R, Ascenção Carolline F R, Feng Kevin, Kim Dongsung, Oberly Susannah, Freire Raimundo, Smolka Marcus B
Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY 14853, USA.
Unidad de Investigación, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320 La Laguna, Tenerife, Spain.
NAR Cancer. 2020 Jun;2(2):zcaa006. doi: 10.1093/narcan/zcaa006. Epub 2020 May 1.
Most cancer cells experience oncogene-induced replication stress and, as a result, exhibit high intrinsic activation of the ATR kinase. Although cancer cells often become more dependent on ATR for survival, the precise mechanism by which ATR signaling ensures cancer cell fitness and viability remains incompletely understood. Here, we find that intrinsic ATR signaling is crucial for the ability of cancer cells to promote DNA end resection, the first step in homology-directed DNA repair. Inhibition of ATR over multiple cell division cycles depletes the pool of pro-resection factors and prevents the engagement of RAD51 as well as RAD52 at nuclear foci, leading to toxic DNA-PKcs signaling and hypersensitivity to PARP inhibitors. The effect is markedly distinct from acute ATR inhibition, which blocks RAD51-mediated repair but not resection and engagement of RAD52. Our findings reveal a key pro-resection function for ATR and define how ATR inhibitors can be used for effective manipulation of DNA end resection capacity and DNA repair outcomes in cancer cells.
大多数癌细胞会经历癌基因诱导的复制应激,因此表现出ATR激酶的高度内在激活。尽管癌细胞通常在生存方面变得更加依赖ATR,但ATR信号确保癌细胞适应性和活力的确切机制仍未完全了解。在这里,我们发现内在的ATR信号对于癌细胞促进DNA末端切除的能力至关重要,DNA末端切除是同源定向DNA修复的第一步。在多个细胞分裂周期中抑制ATR会耗尽促切除因子库,并阻止RAD51以及RAD52在核灶处的结合,导致有毒的DNA-PKcs信号传导以及对PARP抑制剂的超敏反应。这种效应与急性ATR抑制明显不同,急性ATR抑制会阻断RAD51介导的修复,但不会阻断RAD52的切除和结合。我们的研究结果揭示了ATR的关键促切除功能,并确定了如何使用ATR抑制剂有效操纵癌细胞中的DNA末端切除能力和DNA修复结果。